A New Proposal for Children's "Digital Stress Eye Fatigue": Rohto Pharmaceutical Launches "Rohto Eye Vision," Featuring Japan's Only*1 BTA Formulation Focused on Pediatric Eye Inflammation

AI Summary (NQ-processed)

Rohto Pharmaceutical is set to launch "Rohto Eye Vision" on March 26, 2026, an eye drop designed to combat "digital stress-induced eye fatigue" in children. The product features a proprietary BTA formulation that addresses eye surface inflammation, a common side effect of prolonged digital device use in children.